Why is CRISP™ a superior method to what we are doing now?

Full transparency: CRISP™ may not be superior to what you are doing now. This is especially true if your organization has been executing M&A transactions for a protracted period and has adequate staff and budget dedicated to the process.

On the other hand, if executing M&A initiatives in your organization suffer from any of the 10 items that Boston Consulting Group has recently determined cause problems for transactions, CRISP™  can mitigate 6.5 of them (*).

  1. Poor Integration Strategy and Execution *
  2. Cultural Misalignment *
  3. Inadequate Due Diligence *
  4. Overestimation of Synergies
  5. Lack of Clear Vision and Objectives *.5
  6. Overpaying
  7. External Factors
  8. Leadership and Management *
  9. Failure to Engage Key Stakeholders *
  10. Lack of Effective Communication *

Collaboration underpins Improving all these problems. Here’s what an actual colleague said when asked … §

 

The fastest way to determine whether your organization will benefit from adopting CRISP™ is to use the free AI-driven Initial Viability Tool to perform a “non-invasive” analysis and recommendation. Go there now -> CRISP™ IVT.

§ Colleague testimonials are in their own words (but not voices), edited for length, and rendered as avatars for confidentiality.